Ausgabe 2/2021
Inhalt (21 Artikel)
Thrombus straddling a patent foramen ovale in a patient with pulmonary embolism related to essential thrombocythemia
Jiang-Shan Tan, Xin-Xin Yan, Xin Gao, Song Hu, Lu Hua
Cytokeratin expression in therapy-related leukemia
Hiromi Kinoshita, Daisuke Okamura, Tsugumi Sato, Yoshitada Taji, Hidekazu Kayano, Masanori Yasuda, Norio Asou, Yasuhiro Ebihara
Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry
Joan-Lluis Vives-Corrons, Elena Krishnevskaya, Ines Hernandez Rodriguez, Agueda Ancochea
The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma
László Imre Pinczés, Roxána Szabó, Zsófia Miltényi, Árpád Illés
Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome
Paul R. J. Ames, Mira Merashli, Bucci Tommaso, Luigi Iannaccone, Vincenzo Marottoli, Antonio Ciampa
Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study
Joanna Zuk, Elzbieta Papuga-Szela, Lech Zareba, Anetta Undas
Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes
Sanjay Mishra, Shyampyari Jaiswar, Sumaiya Saad, Shalini Tripathi, Nisha Singh, Sujata Deo, Monika Agarwal, Neetu Mishra
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents
Shuku Sato, Wataru Kamata, Satomi Okada, Yotaro Tamai
Chronic myeloid leukemia in solid organ transplant patients: a case series
Irina Amitai, Adi Shacham Abulafia, Pia Raanani, Jeffrey H. Lipton
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR
Naoki Takezako, Hirohiko Shibayama, Hiroshi Handa, Shotaro Hagiwara, Shuji Ozaki, Kenshi Suzuki, Hiroshi Kosugi, Masaki Ri, Isamu Sugiura, Ilseung Choi, Toshihiro Miyamoto, Shinsuke Iida
Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis
Yujia Wang, Lushuang Xu, Yang Liu, Yuzhe Hu, Qiang Shi, Lixue Jin, Lijun Yang, Pingzhang Wang, Kunshan Zhang, Xiaojun Huang, Qing Ge, Jin Lu
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells
Kana Nakatani, Hidemasa Matsuo, Yutarou Harata, Moe Higashitani, Asami Koyama, Mina Noura, Yoko Nishinaka-Arai, Yasuhiko Kamikubo, Souichi Adachi
Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation
Xue-Wen Zhang, Xing Shen, Wen-Yue Long, He Xiao, Feng-Jun Li, Shuang Xing, Guo-Lin Xiong, Zu-Yin Yu, Yu-Wen Cong
Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome
Changfeng Man, Mengmeng Wang, Guangli Yin, Jiayu Huang, Wanying Cheng, Xing Wu, Lingling Liu, Xin Gao, Jujuan Wang, Tian Tian, Limin Duan, Ji Xu, Hongxia Qiu
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost
Shinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, Hirotaka Kazama, Hyunchung Kim, Bruce Crawford, Takanori Teshima
The clonal evolution during long-term clinical course of multiple myeloma
Yuko Mishima, Yuji Mishima, Yuko Shirouchi, Noriko Nishimura, Masahiro Yokoyama, Takashi Okabe, Norihito Inoue, Hideki Uryu, Takanori Fukuta, Kiyohiko Hatake, Yasuhito Terui
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion
Shuki Oya, Satoshi Morishige, Hidetoshi Ozawa, Kensuke Sasaki, Yuichiro Semba, Yoshitaka Yamasaki, Takayuki Nakamura, Kazutoshi Aoyama, Ritsuko Seki, Fumihiko Mouri, Koichi Osaki, Toshihiro Miyamoto, Takahiro Maeda, Koji Nagafuji
Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation
Naoki Sakata, Munehiro Okano, Ryujin Masako, Ai Tanaka, Yuhei Yamashita, Takahiro Karasuno, Ken-Ichi Imadome, Mitsuru Okada, Keisuke Sugimoto
Ruxolitinib for hematopoietic cell transplantation-associated hemophagocytic lymphohistiocytosis
Rintaro Ono, Miho Ashiarai, Shinsuke Hirabayashi, Kazuyoshi Mizuki, Yosuke Hosoya, Hiroki Yoshihara, Junya Ohtake, Shinichiro Mori, Atsushi Manabe, Daisuke Hasegawa
Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus
Risa Matsumura, Shinji Mochizuki, Natsuki Maruyama, Yusuke Morishita, Hiroshi Kawaguchi, Satoshi Okada, Miyuki Tsumura, Shunsaku Kaji, Junya Shimizu, Akira Shimada, Masao Kobayashi
Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group
Tadashi Kumamoto, Hiroaki Goto, Chitose Ogawa, Toshinori Hori, Takao Deguchi, Takuya Araki, Akiko M. Saito, Atsushi Manabe, Keizo Horibe, Hidemi Toyoda